These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37971739)

  • 1. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer.
    Kabirian R; Franzoi MA; Havas J; Coutant C; Tredan O; Levy C; Cottu P; Dhaini Mérimèche A; Guillermet S; Ferrero JM; Giacchetti S; Petit T; Dalenc F; Rouanet P; Everhard S; Martin AL; Pistilli B; Lambertini M; Vaz-Luis I; Di Meglio A
    JAMA Netw Open; 2023 Nov; 6(11):e2343910. PubMed ID: 37971739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer.
    Abusief ME; Missmer SA; Ginsburg ES; Weeks JC; Partridge AH
    Fertil Steril; 2012 Jan; 97(1):154-9. PubMed ID: 22192139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer.
    Turnbull AK; Patel S; Martinez-Perez C; Rigg A; Oikonomidou O
    Breast Cancer Res Treat; 2021 Feb; 186(1):237-245. PubMed ID: 33047206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer.
    Anders C; Marcom PK; Peterson B; Gu L; Unruhe S; Welch R; Lyons P; Behera M; Copland S; Kimmick G; Shaw H; Snyder S; Antenos M; Woodruff T; Blackwell K
    Cancer Invest; 2008; 26(3):286-95. PubMed ID: 18317970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.
    Ruddy KJ; O'Neill A; Miller KD; Schneider BP; Baker E; Sparano JA; Dang C; Northfelt DW; Sledge GW; Partridge AH
    Breast Cancer Res Treat; 2014 Apr; 144(3):591-7. PubMed ID: 24584876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-related amenorrhea in premenopausal women with breast cancer.
    Lee S; Kil WJ; Chun M; Jung YS; Kang SY; Kang SH; Oh YT
    Menopause; 2009; 16(1):98-103. PubMed ID: 18849877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
    Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
    Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive Use in Premenopausal Women With Early Breast Cancer.
    Lambertini M; Massarotti C; Havas J; Pistilli B; Martin AL; Jacquet A; Coutant C; Coussy F; Mérimèche AD; Lerebours F; Rousset-Jablonski C; Jouannaud C; Rigal O; Fournier M; Soulie P; Franzoi MA; Del Mastro L; Partridge AH; André F; Vaz-Luis I; Di Meglio A
    JAMA Netw Open; 2022 Sep; 5(9):e2233137. PubMed ID: 36149651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.
    Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W
    PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
    Swain SM; Land SR; Ritter MW; Costantino JP; Cecchini RS; Mamounas EP; Wolmark N; Ganz PA
    Breast Cancer Res Treat; 2009 Jan; 113(2):315-20. PubMed ID: 18302020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.
    Su HI; Sammel MD; Green J; Velders L; Stankiewicz C; Matro J; Freeman EW; Gracia CR; DeMichele A
    Cancer; 2010 Feb; 116(3):592-9. PubMed ID: 19918920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer.
    Ruddy KJ; Schaid DJ; Partridge AH; Larson NB; Batzler A; Häberle L; Dittrich R; Widschwendter P; Fink V; Bauer E; Schwitulla J; Rübner M; Ekici AB; Aivazova-Fuchs V; Stewart EA; Beckmann MW; Ginsburg E; Wang L; Weinshilboum RM; Couch FJ; Janni W; Rack B; Vachon C; Fasching PA
    Fertil Steril; 2019 Oct; 112(4):731-739.e1. PubMed ID: 31371054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
    Bines J; Oleske DM; Cobleigh MA
    J Clin Oncol; 1996 May; 14(5):1718-29. PubMed ID: 8622093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.
    Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF
    Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
    Velikova G; Morden JP; Haviland JS; Emery C; Barrett-Lee P; Earl H; Bloomfield D; Brunt AM; Canney P; Coleman R; Verrill M; Wardley A; Bertelli G; Ellis P; Stein R; Bliss JM; Cameron D;
    Lancet Oncol; 2023 Dec; 24(12):1359-1374. PubMed ID: 37926100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
    Pistilli B; Mazouni C; Zingarello A; Faron M; Saghatchian M; Grynberg M; Spielmann M; Kerbrat P; Roché H; Lorgis V; Bachelot T; Campone M; Levy C; Gonçalves A; Lesur A; Veyret C; Vanlemmens L; Lemonnier J; Delaloge S
    Clin Breast Cancer; 2019 Feb; 19(1):63-70. PubMed ID: 30241966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
    Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.